Akash Chaurasiya

864 total citations
24 papers, 641 citations indexed

About

Akash Chaurasiya is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Akash Chaurasiya has authored 24 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 7 papers in Pharmaceutical Science and 6 papers in Molecular Biology. Recurrent topics in Akash Chaurasiya's work include Nanoparticle-Based Drug Delivery (8 papers), Drug Solubulity and Delivery Systems (5 papers) and Analytical Chemistry and Chromatography (4 papers). Akash Chaurasiya is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Drug Solubulity and Delivery Systems (5 papers) and Analytical Chemistry and Chromatography (4 papers). Akash Chaurasiya collaborates with scholars based in India, Pakistan and Germany. Akash Chaurasiya's co-authors include Ajeet Kumar Singh, Rama Mukherjee, Roop K. Khar, Dinesh Asati, Gautam Mishra, Anshumali Awasthi, Sakshi Priya, Gautam Singhvi, Anekant Jain and Yashwant Gupta and has published in prestigious journals such as Life Sciences, International Journal of Biological Macromolecules and ACS Sustainable Chemistry & Engineering.

In The Last Decade

Akash Chaurasiya

23 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akash Chaurasiya India 12 298 183 140 57 57 24 641
Ahmed R. Gardouh Egypt 13 390 1.3× 171 0.9× 134 1.0× 50 0.9× 62 1.1× 41 703
Neena Bedi India 14 280 0.9× 168 0.9× 84 0.6× 42 0.7× 68 1.2× 67 611
Naveen Chella India 16 416 1.4× 214 1.2× 117 0.8× 62 1.1× 59 1.0× 38 841
Kwan Hyung Cho South Korea 18 377 1.3× 169 0.9× 150 1.1× 61 1.1× 90 1.6× 64 828
Young‐Guk Na South Korea 18 348 1.2× 193 1.1× 175 1.3× 43 0.8× 119 2.1× 47 795
H. Yeşim Karasulu Türkiye 18 673 2.3× 171 0.9× 103 0.7× 38 0.7× 51 0.9× 57 1.0k
Karthik Yadav Janga United States 17 642 2.2× 319 1.7× 104 0.7× 39 0.7× 60 1.1× 25 1.0k
Vikas Bali India 14 571 1.9× 155 0.8× 90 0.6× 44 0.8× 52 0.9× 18 856

Countries citing papers authored by Akash Chaurasiya

Since Specialization
Citations

This map shows the geographic impact of Akash Chaurasiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akash Chaurasiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akash Chaurasiya more than expected).

Fields of papers citing papers by Akash Chaurasiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akash Chaurasiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akash Chaurasiya. The network helps show where Akash Chaurasiya may publish in the future.

Co-authorship network of co-authors of Akash Chaurasiya

This figure shows the co-authorship network connecting the top 25 collaborators of Akash Chaurasiya. A scholar is included among the top collaborators of Akash Chaurasiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akash Chaurasiya. Akash Chaurasiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaurasiya, Akash, et al.. (2025). Ultra-Fast Humidity Sensor for Breath Monitoring Using Cellulose Nanocrystal Film Derived from Banana Trunk. IEEE Sensors Letters. 9(7). 1–4.
2.
3.
Paliwal, Rishi, et al.. (2024). Dynamic intervention to enhance the stability of PEGylated Ibrutinib loaded lipidic nano-vesicular systems: transitioning from colloidal dispersion to lyophilized product. Drug Delivery and Translational Research. 14(11). 3269–3290. 4 indexed citations
4.
Paliwal, Rishi, et al.. (2024). QbD Enabled Development and Evaluation of Pazopanib Loaded Nanoliposomes for PDAC Treatment. AAPS PharmSciTech. 25(5). 97–97. 3 indexed citations
5.
Kumar, Hitesh, et al.. (2023). Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics. Pharmaceuticals. 16(2). 196–196. 60 indexed citations
6.
Singh, Himani, et al.. (2023). Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities. AAPS PharmSciTech. 24(4). 102–102. 11 indexed citations
7.
Chaurasiya, Akash, et al.. (2023). Multifunctional targetable liposomal drug delivery system in the management of leukemia: Potential, opportunities, and emerging strategies. Life Sciences. 325. 121771–121771. 15 indexed citations
8.
Mehra, Neelesh Kumar, et al.. (2022). An expanding horizon of complex injectable products: development and regulatory considerations. Drug Delivery and Translational Research. 13(2). 433–472. 23 indexed citations
9.
Priya, Sakshi, et al.. (2022). Polysaccharide-based nanofibers for pharmaceutical and biomedical applications: A review. International Journal of Biological Macromolecules. 218. 209–224. 70 indexed citations
10.
Rani, Sarita, Akash Chaurasiya, Onkar P. Kulkarni, et al.. (2022). N-2-Hydroxypropylmethacrylamide–Polycaprolactone Polymeric Micelles in Co-delivery of Proteasome Inhibitor and Polyphenol: Exploration of Synergism or Antagonism. Molecular Pharmaceutics. 20(1). 524–544. 3 indexed citations
11.
Paliwal, Rishi, et al.. (2021). Development of Nanomedicines and Nano-Similars: Recent Advances in Regulatory Landscape. Current Pharmaceutical Design. 28(2). 165–177. 10 indexed citations
12.
Chaurasiya, Akash, et al.. (2021). A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challenges. Drug Delivery and Translational Research. 12(7). 1569–1587. 42 indexed citations
13.
14.
Gupta, Umesh, et al.. (2021). Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology. 95. 107508–107508. 20 indexed citations
15.
Singh, Ajeet, Akash Chaurasiya, Musarrat Husain Warsi, et al.. (2012). ORAL PHARMACOKINETIC STUDY OF EXEMESTANE SMEDDS AND SUSPENSION IN RAT PLASMA BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRIC ANALYSIS. Journal of Liquid Chromatography & Related Technologies. 35(15). 2162–2174. 2 indexed citations
16.
Pandey, Ravi Shankar, et al.. (2011). Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B. International Immunopharmacology. 11(10). 1516–1522. 34 indexed citations
17.
Singh, Ajeet Kumar, Akash Chaurasiya, Gaurav Jain, et al.. (2009). High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats. Talanta. 78(4-5). 1310–1314. 26 indexed citations
18.
Singh, Ajeet Kumar, Akash Chaurasiya, Anshumali Awasthi, et al.. (2009). Oral Bioavailability Enhancement of Exemestane from Self-Microemulsifying Drug Delivery System (SMEDDS). AAPS PharmSciTech. 10(3). 906–916. 132 indexed citations
19.
Singh, Ajeet Kumar, et al.. (2008). Exemestane Loaded Self-Microemulsifying Drug Delivery System (SMEDDS): Development and Optimization. AAPS PharmSciTech. 9(2). 628–634. 95 indexed citations
20.
Jain, Sanjay, et al.. (2008). Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting. Journal of Microencapsulation. 25(5). 289–297. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026